| Typicality: | 0.493 |
| Saliency: | 0.392 |
| as an experimental drug | 4 | manner |
| after clinical testing | 4 | temporal |
| almost daily | 3 | temporal |
| drug → be released to → the market | 18 |
| drug → be released into → the market | 12 |
| drug → be released onto → the market | 10 |
| drug → be released on → the market | 9 |
| drug → be released in → the market | 5 |
| drug → be released into → the marketplace | 3 |
| negative | neutral | positive |
| 0.307 | 0.575 | 0.119 |
| Raw frequency | 57 |
| Normalized frequency | 0.392 |
| Modifier score | 0.733 |
| Perplexity | 91.507 |